Similar articles

• Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

  Turka LA, Dayton J, Sinclair G, Thompson CB, Mitchell BS. Turka LA, et al. J Clin Invest. 1991 Mar;87(3):940-8. doi: 10.1172/JCI115101. J Clin Invest. 1991. PMID: 1999502 Free PMC article.
• IMP dehydrogenase inhibitors as immunomodulators.

  Mitchell BS, Dayton JS, Turka LA, Thompson CB. Mitchell BS, et al. Ann N Y Acad Sci. 1993 Jun 23;685:217-24. doi: 10.1111/j.1749-6632.1993.tb35869.x. Ann N Y Acad Sci. 1993. PMID: 8103312
• Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.

  Dayton JS, Turka LA, Thompson CB, Mitchell BS. Dayton JS, et al. Mol Pharmacol. 1992 Apr;41(4):671-6. Mol Pharmacol. 1992. PMID: 1569921
• [Mizoribine].

  Kondo H, Iizuka N. Kondo H, et al. Nihon Rinsho. 2005 May;63 Suppl 5:708-12. Nihon Rinsho. 2005. PMID: 15954433 Review. Japanese. No abstract available.
• T-cell depletion for transplant tolerance induction: promises and hurdles.

  Dumont FJ. Dumont FJ. Curr Opin Investig Drugs. 2003 Nov;4(11):1275-8. Curr Opin Investig Drugs. 2003. PMID: 14758765 Review. No abstract available.